Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of RAMM Pharma Corp.
No Price
Closing Price XCNQ 20.04.2026:
0,02 CAD
20.04.2026 13:04
Current Prices from RAMM Pharma Corp.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
CSE LISTED
RAMM.CN
CAD
20.04.2026 13:04
0,02 CAD
-
Share Float & Liquidity
Free Float68,57 %
Shares Float81,87 M
Shares Outstanding119,39 M
Company Profile for RAMM Pharma Corp. Share
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
